|
|
Vol. 13.12 – 11 April, 2024
|
|
|
|
|
|
|
|
Researchers introduced a dual recombinase-mediated intersectional genetic lineage tracing approach, enabling precise investigation of alveolar type 2 cellular origins during lung homeostasis, injury, and repair. [Cell]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Investigators showed that planar cell polarity (PCP) was dispensable in the airway epithelium for sacculation. They found a Celsr1-independent role for the PCP component Vangl in the pulmonary mesenchyme.
[Developmental Cell]
|
|
|
|
|
|
Researchers investigated the interactive roles of TGF-β1, ubiquitin-specific-processing protease 7 (USP7), and yes-associated protein (YAP) in ferroptosis during sepsis-secondary acute lung injury. [iScience]
|
|
|
|
|
|
|
|
Using comprehensive genomic profiling among >600,000 patients, the authors identified activating MET tyrosine kinase domain point mutations as putative oncogenic drivers across diverse cancers, with a frequency of ~0.5%. [Cancer Discovery]
|
|
|
|
|
|
To better understand the clonal architecture and genomic landscape of non-smoking-related oncogene-driven tumors in smokers compared to typical-smoking NSCLCs, scientists investigated genomic and transcriptomic alterations in 173 tumor sectors from 48 NSCLC patients.
[Cancer Research]
|
|
|
|
|
|
Expression and methylation of dopamine receptor D1 (DRD1) were measured using RNAseq and RT-PCR in NSCLC samples and validated using publicly available datasets. [Molecular Oncology]
|
|
|
|
|
|
|
|
|
Investigators discuss the current state of the art in cell-free (cf)DNA methylation analysis, examine the unique features and limitations of these new methods in a clinical context, propose two models for applying cfDNA methylation data for lung cancer screening, and discuss future research directions. [Trends in Molecular Medicine]
|
|
|
|
|
|
|
|
In a collaborative effort to end lung cancer, the American Lung Association and LUNGevity Foundation have joined forces to invest $3 million over the next three years in research aimed at intercepting lung cancer. [American Lung Association]
|
|
|
|
|
|
|
|
April 24 – 26, 2024 Vienna, Austria
|
|
|
|
|
|
|
|
|
|
|
Indiana University School of Medicine – Indianapolis, Indiana, United States
|
|
|
|
|
|
|
Singapore Institute Of Technology – Singapore, Singapore
|
|
|
|
|
|
|
Maynooth University – Maynooth, Ireland
|
|
|
|
|
|
|
Brigham and Women’s Hospital – Boston, Massachusetts, United States
|
|
|
|
|
|
|
EPFL – Lausanne, Switzerland
|
|
|
|
|
|